NTRB
Price
$5.51
Change
-$0.26 (-4.51%)
Updated
Apr 3, 04:58 PM (EDT)
Capitalization
64.08M
29 days until earnings call
VRAX
Price
$1.04
Change
-$0.10 (-8.77%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
4.95M
Ad is loading...

NTRB vs VRAX

Header iconNTRB vs VRAX Comparison
Open Charts NTRB vs VRAXBanner chart's image
Nutriband
Price$5.51
Change-$0.26 (-4.51%)
Volume$181
Capitalization64.08M
Virax Biolabs Group
Price$1.04
Change-$0.10 (-8.77%)
Volume$100
Capitalization4.95M
NTRB vs VRAX Comparison Chart
Loading...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRB vs. VRAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRB is a Hold and VRAX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (NTRB: $5.77 vs. VRAX: $1.14)
Brand notoriety: NTRB and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTRB: 12% vs. VRAX: 28%
Market capitalization -- NTRB: $64.08M vs. VRAX: $4.52M
NTRB [@Biotechnology] is valued at $64.08M. VRAX’s [@Biotechnology] market capitalization is $4.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRB’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • NTRB’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRAX is a better buy in the long-term than NTRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRB’s TA Score shows that 4 TA indicator(s) are bullish while VRAX’s TA Score has 5 bullish TA indicator(s).

  • NTRB’s TA Score: 4 bullish, 6 bearish.
  • VRAX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than NTRB.

Price Growth

NTRB (@Biotechnology) experienced а -12.71% price change this week, while VRAX (@Biotechnology) price change was -10.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

NTRB is expected to report earnings on May 02, 2025.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRB($64.1M) has a higher market cap than VRAX($4.95M). NTRB YTD gains are higher at: 22.505 vs. VRAX (-49.333). VRAX (-6.43M) and NTRB (-6.52M) have comparable annual earnings (EBITDA) . VRAX has more cash in the bank: 7.29M vs. NTRB (5.7M). NTRB has less debt than VRAX: NTRB (200K) vs VRAX (380K). NTRB has higher revenues than VRAX: NTRB (2.02M) vs VRAX (84.9K).
NTRBVRAXNTRB / VRAX
Capitalization64.1M4.95M1,295%
EBITDA-6.52M-6.43M101%
Gain YTD22.505-49.333-46%
P/E RatioN/AN/A-
Revenue2.02M84.9K2,382%
Total Cash5.7M7.29M78%
Total Debt200K380K53%
FUNDAMENTALS RATINGS
NTRB: Fundamental Ratings
NTRB
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTRBVRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KROS10.040.49
+5.13%
Keros Therapeutics
ENVA103.673.75
+3.75%
Enova International
GROV1.360.02
+1.49%
Grove Collaborative Holdings
CAT334.664.09
+1.24%
Caterpillar
CFR124.761.06
+0.86%
Cullen/Frost Bankers

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
-0.17%
VRAX - NTRB
31%
Poorly correlated
+3.83%
NOXOF - NTRB
29%
Poorly correlated
N/A
SYRE - NTRB
27%
Poorly correlated
+1.27%
STOK - NTRB
27%
Poorly correlated
+5.94%
MBRX - NTRB
24%
Poorly correlated
+0.20%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+3.83%
ALZN - VRAX
41%
Loosely correlated
+4.51%
SNGX - VRAX
36%
Loosely correlated
N/A
NCNA - VRAX
35%
Loosely correlated
+1.13%
NTRB - VRAX
31%
Poorly correlated
-0.17%
GOVX - VRAX
31%
Poorly correlated
+9.26%
More